Get the Stockscreener App
39.48
1.05%
-0.42
Pre-market:
39.71
0.23
+0.58%
Bruker Corp stock is traded at $39.48, with a volume of 1.54M.
It is down -1.05% in the last 24 hours and up +16.98% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$39.90
Open:
$39.9
24h Volume:
1.54M
Relative Volume:
0.67
Market Cap:
$6.01B
Revenue:
$3.44B
Net Income/Loss:
$-8.30M
P/E Ratio:
-265.50
EPS:
-0.1487
Net Cash Flow:
$43.30M
1W Performance:
+3.22%
1M Performance:
+16.98%
6M Performance:
+9.06%
1Y Performance:
+2.73%
1-Day Range:
$39.19
$40.75
1-Week Range:
$36.52
$40.78
52-Week Range:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
39.48 | 6.07B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
BRKR (NASDAQ: BRKR) director sale notice — 2,000 shares via option - Stock Titan
BRKR SEC FilingsBruker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $45 - 富途牛牛
Bruker Corp. Opens with 6.41% Gain, Marking Significant Gap Up in Stock Performance - Markets Mojo
Bruker (BRKR) Unveils Innovative NMR Products at Experimental Co - GuruFocus
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 - Eagle-Tribune
Bruker rolls out NMR tools with 30,000x signal boost, more automation - Stock Titan
Bruker Corp (BSP:B2RK34) Stock News, Headlines & Updates - GuruFocus
Bruker Corporation 8-K SEC Filing: Company Details, Key Identifiers, and Listing Information (April 10, 2026) 2122 - Minichart
[ARS] BRUKER CORP SEC Filing - Stock Titan
Bruker (NASDAQ: BRKR) sets 2026 virtual meeting, pay and auditor votes - Stock Titan
Bruker Corp (BRKR) director Bernard Thierry listed in Form 3 filing - Stock Titan
Bruker (BRKR) BioSpin president to exit with $1.02M separation deal - Stock Titan
Bruker (BSP:B2RK34) Cyclically Adjusted Price-to-FCF : (As of Apr. 10, 2026) - GuruFocus
Bruker Corporation (BRKR) stock price, news, quote and history - Yahoo Finance UK
Bruker (BSP:B2RK34) Change In Other Working Capital : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Sale Of Property, Plant, Equipment : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Change In Prepaid Assets : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Purchase Of Investment : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Construction In Progress : R$0 Mil (As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Asset Impairment Charge : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker Corp (BSP:B2RK34) Valuation: Significantly Undervalued - GuruFocus
Bruker (BSP:B2RK34) Net Income (Discontinued Operations) : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker Corp Stock Intrinsic Values - GuruFocus
Bruker (BSP:B2RK34) Shiller PE Ratio : (As of Apr. 10, 2026) - GuruFocus
Who's Buying or Selling Bruker Corp (BSP:B2RK34) Stock Today? - GuruFocus
Bruker Corp Stock Operating Data - GuruFocus
Bruker Corp (BSP:B2RK34) Competitors 2026 - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Earnings Transcripts - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Price & 30 Year Financial Data - GuruFocus
Bruker Corp (BSP:B2RK34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Bruker Corp (BSP:B2RK34) Dividend - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Bruker Corp Stock Baskets - GuruFocus
Bruker Corp (BSP:B2RK34) DCF Valuation - GuruFocus
Bruker Corp (BSP:B2RK34)Valuation Measures & Financial Statistics - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Price, Trades & News - GuruFocus
Bruker Corp Stock Warning Signs - GuruFocus
A Look At Bruker (BRKR) Valuation After New AFM IR Semiconductor Collaboration With Imec - Yahoo Finance
Bruker-imec Development Project Advances Semiconductor Metrology Technique | Business | Apr 2026 - Photonics Spectra
Bruker-imec Development Project aims Advance Semiconductor Metrology Technique | Business | Apr 2026 - Photonics Spectra
Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $40 - Moomoo
Bruker (BRKR) Advances AFM-IR Technology for Semiconductor Innovation - GuruFocus
Bruker Collaborates With Imec to Expand NanoIR Spectroscopy Into Semiconductor Research - Moomoo
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research – Company Announcement - Financial Times
Bruker and imec test sub-5-nanometer tool for next-gen chips - Stock Titan
Bruker Corp 6.375% PRF PERPETUAL USD 0.01Ser A (BRUKV) Stock Price | Live Quotes & Charts | GREY - StocksToTrade
Should You Continue to Retain Bruker Stock in Your Portfolio? - Yahoo Finance
SG Americas Securities LLC Grows Holdings in Bruker Corporation $BRKR - MarketBeat
Context Capital Management, LLC's Bruker Corp(BRKRP.PFD) Holding History - GuruFocus
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):